


GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) has received a Staff Deficiency Letter from The Nasdaq Stock Market notifying GTC that for the last 10 consecutive trading days the aggregate market value of GTCB common stock has fallen below $50 million, the minimum level required for continued listing on the Nasdaq Global Market, as specified by the Marketplace Rule 4450(b)(1)(A). This notice ...
Read more...FRAMINGHAM, Mass.----GTC Biotherapeutics, Inc. has received a Staff Deficiency Letter from The Nasdaq Stock Market notifying GTC that for the last 10 consecutive trading days the aggregate market value of GTCB common stock has fallen below $50 million, the minimum level required for continued listing on the Nasdaq Global Market, as specified by the Marketplace Rule 4450.
Read more...GTC Biotherapeutics, Inc. (6675;"GTC",Nasdaq:GTCB) has received a Staff Deficiency Letter from
Read more...Riverbed Technology, the technology and market leader in wide-area data services, announced today that Gartner has identified the company in its recent July 2008 report, "Market Share: Application Acceleration Equipment, Worldwide 1Q08" as the WOC Advanced Platform worldwide market share leader for 1Q 2008 based on revenue.
Read more...Around £800m worth of counterfeit goods pass through online shopping and auction sites in the UK each year, new research has claimed.
Read more...